(Q39991291)

16 September 2017

title

Somatostatin inhibition of insulin secretion in insulin-producing tumors (English)

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

23 May 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

23 May 2022

author name string

L. A. Scuro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178978

23 May 2022

V. Lo Cascio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178978

23 May 2022

S. Adami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178978

23 May 2022

G. Galvanini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178978

23 May 2022

I. Bianchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178978

23 May 2022

L. Cominacini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178978

23 May 2022

A. Corgnati

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178978

23 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=178978

23 May 2022

publication date

1 June 1976

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:0026049576900561?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

https://api.elsevier.com/content/article/PII:0026049576900561?httpAccept=text/plain

23 May 2022

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

23 May 2022

1 reference

16 September 2017

volume

25

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

603-609

1 reference

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

16 September 2017

cites work

1

179

77

Brazeau

1973

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients.

23 May 2022

2

23

1009

Peracchi

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Inhibition of insulin secretion by somatostatin

23 May 2022

3

2

1299

Alberti

1973

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics

23 May 2022

4

23

876

Gerich

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Effect of somatostatin on plasma glucose and insulin responses to glucagon and tolbutamide in man

23 May 2022

5

39

1057

Gerich

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Editorial: Somatostatin: newcomer from the hypothalamus.

23 May 2022

6

290

963

Brazeau

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Failure of somatostatin to inhibit tolbutamide-induced insulin secretion in patients with insulinomas: a possible diagnostic tool

23 May 2022

7

40

1121

Lorenzi

1975

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Somatostatin Inhibition of Insulin and Gastrin Hypersecretion in Pancreatic Islet-Cell Carcinoma

23 May 2022

8

292

1385

Curnow

1975

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Letter: Somatostatin and insulinoma

23 May 2022

9

1

1426

Christensen

1975

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Immunoassay of insulin with insulin-antibody precipitate

23 May 2022

10

88

137

Hales

1963

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

23 May 2022

11

1

697

Mortimer

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels

23 May 2022

12

290

935

Yen

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Glucagon control of fasting glucose in man.

23 May 2022

13

2

974

Alford

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

23 May 2022

14

184

482

Koerker

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

23 May 2022

15

291

544

Gerich

1974

1 reference

https://api.crossref.org/works/10.1016/0026-0495(76)90056-1

23 May 2022

Identifiers

1 reference

16 September 2017

1 reference